MaxQ Medical Raises $31.5M Series A for Prostate Imaging and Therapy

MaxQ Medical announced $31.5M in Series A financing on August 20, 2026. MaxQ Medical raised a $31.5 million Series A led by Atlantic Blue Ventures, S3 Ventures and Olympus Innovation Ventures to grow its team and advance its clinical program.

Round details

The financing includes backing from Atlantic Blue Ventures, S3 Ventures, Olympus Innovation Ventures, Hillside Capital. The company did not publish a valuation with the announcement.

Round: Series A
Capital announced: $31.5M
Headquarters: Sunnyvale, CA

How the company plans to use the capital

MaxQ Medical said the funds will be used to grow its team and advance its clinical program, and the release said the funding will support clinical evaluations already underway.

Why this matters for GTM teams

The round shows investor backing, including from Olympus Innovation Ventures, for urology technology that aims to image and treat the prostate in one outpatient setting while the system remains investigational.

Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.

Source and methodology

This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.

Primary source: MaxQ Medical Series A announcement.